IL127572A - Pharmaceutical composition and medicament for nasal administration - Google Patents

Pharmaceutical composition and medicament for nasal administration

Info

Publication number
IL127572A
IL127572A IL12757297A IL12757297A IL127572A IL 127572 A IL127572 A IL 127572A IL 12757297 A IL12757297 A IL 12757297A IL 12757297 A IL12757297 A IL 12757297A IL 127572 A IL127572 A IL 127572A
Authority
IL
Israel
Prior art keywords
medicament
pharmaceutical composition
nasal administration
nasal
administration
Prior art date
Application number
IL12757297A
Other languages
English (en)
Other versions
IL127572A0 (en
Inventor
Bengt Bengtsson
Original Assignee
Ferring Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferring Bv filed Critical Ferring Bv
Priority to IL14653797A priority Critical patent/IL146537A0/xx
Publication of IL127572A0 publication Critical patent/IL127572A0/xx
Publication of IL127572A publication Critical patent/IL127572A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/095—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Otolaryngology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL12757297A 1996-06-20 1997-06-10 Pharmaceutical composition and medicament for nasal administration IL127572A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IL14653797A IL146537A0 (en) 1996-06-20 1997-06-10 Method of preparation of desmopressin-containing medicament

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/667,047 US5763398A (en) 1996-06-20 1996-06-20 Nasal administration of desmopressin
PCT/SE1997/001010 WO1997048379A1 (en) 1996-06-20 1997-06-10 Nasal administration of desmopressin

Publications (2)

Publication Number Publication Date
IL127572A0 IL127572A0 (en) 1999-10-28
IL127572A true IL127572A (en) 2003-04-10

Family

ID=24676595

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12757297A IL127572A (en) 1996-06-20 1997-06-10 Pharmaceutical composition and medicament for nasal administration

Country Status (24)

Country Link
US (1) US5763398A (cs)
EP (1) EP0921786A1 (cs)
JP (1) JP2000502358A (cs)
KR (1) KR20000016781A (cs)
CN (1) CN1233952A (cs)
AU (1) AU707527B2 (cs)
BR (1) BR9700797A (cs)
CA (1) CA2258552A1 (cs)
CZ (1) CZ420198A3 (cs)
EE (1) EE9800453A (cs)
HU (1) HUP9903541A3 (cs)
IL (1) IL127572A (cs)
LT (1) LT4621B (cs)
LV (1) LV12230B (cs)
NO (1) NO985936L (cs)
NZ (1) NZ333124A (cs)
PL (1) PL330902A1 (cs)
RO (1) RO120170B1 (cs)
RU (1) RU2173559C2 (cs)
SI (1) SI9720040A (cs)
SK (1) SK176998A3 (cs)
TR (1) TR199802596T2 (cs)
UA (1) UA49888C2 (cs)
WO (1) WO1997048379A1 (cs)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8765177B2 (en) * 1997-09-12 2014-07-01 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets
US7153845B2 (en) * 1998-08-25 2006-12-26 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets
JP2001233787A (ja) * 2000-02-04 2001-08-28 Patents Exploitation Co Bv 小・中サイズのペプチド含有薬学的組成物
EP1121935B1 (en) * 2000-02-04 2008-08-13 Patents Exploitation Company B.V. Pharmaceutical composition containing a small or medium size peptide
IL163666A0 (en) 2002-02-22 2005-12-18 New River Pharmaceuticals Inc Active agent delivery systems and methods for protecting and administering active agents
GB0210397D0 (en) * 2002-05-07 2002-06-12 Ferring Bv Pharmaceutical formulations
US7094545B2 (en) 2003-04-30 2006-08-22 Ferring Bv Pharmaceutical composition as solid dosage form and method for manufacturing thereof
PT1530967E (pt) * 2003-11-13 2006-09-29 Ferring Bv Embalagem blister e uma forma de dosagem solida que compreende desmopressina.
SE0600482L (sv) * 2006-03-02 2006-11-14 Ferring Int Ct Sa Farmaceutisk sammansättning innefattande desmopressin, kiseldioxid och stärkelse
ES2319054B1 (es) * 2007-08-06 2010-02-12 Gp Pharm S.A. Composicion farmaceutica oral de desmopresina.
AU2008283929B2 (en) 2007-08-06 2013-10-10 Serenity Pharmaceuticals, Llc Methods and devices for desmopressin drug delivery
US8986253B2 (en) 2008-01-25 2015-03-24 Tandem Diabetes Care, Inc. Two chamber pumps and related methods
US20100286045A1 (en) 2008-05-21 2010-11-11 Bjarke Mirner Klein Methods comprising desmopressin
PT3225249T (pt) * 2008-05-21 2019-01-17 Ferring Bv Desmopressina orodispersível para aumentar o período inicial de sono não perturbado pela nocturia
US11963995B2 (en) 2008-05-21 2024-04-23 Ferring B.V. Methods comprising desmopressin
US8408421B2 (en) 2008-09-16 2013-04-02 Tandem Diabetes Care, Inc. Flow regulating stopcocks and related methods
CA2737461A1 (en) 2008-09-19 2010-03-25 Tandem Diabetes Care, Inc. Solute concentration measurement device and related methods
SG172344A1 (en) * 2008-12-22 2011-07-28 Allergan Inc Intranasal desmopressin administration
US9539302B2 (en) 2009-06-18 2017-01-10 Allergan, Inc. Safe desmopressin administration
US8926561B2 (en) 2009-07-30 2015-01-06 Tandem Diabetes Care, Inc. Infusion pump system with disposable cartridge having pressure venting and pressure feedback
FR2954774B1 (fr) * 2009-10-30 2012-01-06 Michelin Soc Tech Methode de preparation d'un melange maitre de caoutchouc naturel et de silice
US9180242B2 (en) 2012-05-17 2015-11-10 Tandem Diabetes Care, Inc. Methods and devices for multiple fluid transfer
US9173998B2 (en) 2013-03-14 2015-11-03 Tandem Diabetes Care, Inc. System and method for detecting occlusions in an infusion pump
RU2605311C1 (ru) * 2015-07-14 2016-12-20 Федеральное государственное бюджетное научное учреждение "Институт экспериментальной медицины" (ФГБНУ "ИЭМ") Способ лечения болевого синдрома у больных с дегенеративно-дистрофическими заболеваниями позвоночника

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH495957A (de) * 1966-09-15 1970-09-15 Ceskoslovenska Akademie Ved Verfahren zur Herstellung eines antidiuretisch wirksamen Polypeptids
US4271068A (en) * 1968-05-10 1981-06-02 Ciba-Geigy Corporation Process for the manufacture of cystine-containing peptides
CH517705A (de) * 1969-12-16 1972-01-15 Ciba Geigy Ag Verfahren zur Herstellung von Cystin-haltigen Peptiden
US3929758A (en) * 1974-09-12 1975-12-30 Armour Pharma Cyclization of cysteine-containing peptides
US4033940A (en) * 1975-11-12 1977-07-05 Armour Pharmaceutical Company Cyclization of peptides
US4093610A (en) * 1977-01-31 1978-06-06 American Home Products Corporation Process for producing triglycyl-lysine vasopressin and intermediates therefor
US4216141A (en) * 1978-07-19 1980-08-05 The Salk Institute For Biological Studies Method for cyclization of peptides
DE2923787A1 (de) * 1979-06-12 1980-12-18 Max Planck Gesellschaft Verfahren zur selektiven bildung von disulfidbruecken in polypeptiden und die dabei erhaltenen produkte als wirkstoffe enthaltende arzneimittel
IE56021B1 (en) * 1982-10-13 1991-03-27 Akzo Nv Peptides
US5066716A (en) * 1988-12-13 1991-11-19 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Synthesis of chloroacetyl and bromoacetyl modified peptides for the preparation of synthetic peptide polymers, conjugated peptides, and cyclic peptides
ES2158898T3 (es) * 1993-06-29 2001-09-16 Ferring Bv Composiciones para la administracion de desmopresina por via nasal.
US5500413A (en) * 1993-06-29 1996-03-19 Ferring Ab Process for manufacture of 1-deamino-8-D-arginine vasopressin
US5482931A (en) * 1993-06-29 1996-01-09 Ferring Ab Stabilized pharmaceutical peptide compositions

Also Published As

Publication number Publication date
IL127572A0 (en) 1999-10-28
PL330902A1 (en) 1999-06-07
CA2258552A1 (en) 1997-12-24
UA49888C2 (uk) 2002-10-15
US5763398A (en) 1998-06-09
TR199802596T2 (xx) 1999-03-22
EP0921786A1 (en) 1999-06-16
CN1233952A (zh) 1999-11-03
LV12230B (en) 1999-06-20
KR20000016781A (ko) 2000-03-25
AU3280297A (en) 1998-01-07
NO985936L (no) 1999-02-16
RO120170B1 (ro) 2005-10-28
JP2000502358A (ja) 2000-02-29
LT98188A (en) 1999-11-25
HUP9903541A3 (en) 2000-10-30
NZ333124A (en) 1999-05-28
WO1997048379A1 (en) 1997-12-24
HUP9903541A2 (hu) 2000-04-28
CZ420198A3 (cs) 1999-04-14
BR9700797A (pt) 1998-10-06
SI9720040A (sl) 1999-08-31
SK176998A3 (en) 1999-05-07
AU707527B2 (en) 1999-07-15
RU2173559C2 (ru) 2001-09-20
EE9800453A (et) 1999-08-16
LV12230A (lv) 1999-03-20
LT4621B (lt) 2000-02-25
NO985936D0 (no) 1998-12-17

Similar Documents

Publication Publication Date Title
IL127572A (en) Pharmaceutical composition and medicament for nasal administration
GB2303064B (en) Medicament for nasal administration
HRP960300B1 (en) Inhaler for administration of blister-packed medicaments
HUP0002645A3 (en) Phospholipid containing pharmaceutical composition for treating sleep apnea and apparatus for enabling the administration thereof
EP0873749A4 (en) GELLED PRODUCTS FOR ORAL ADMINISTRATION
AU1529397A (en) Delivery system for localized administration of medicaments to the upper respiratory tract
HUP0101293A3 (en) Aspb28-human insulin comprising pharmaceutical composition administered by inhalation and their use
IL115097A0 (en) Pharmaceutical compositions adapted for oral administration
ZA942804B (en) Oral drug delivery compositions and methods
ZA9710994B (en) Pharmaceutical formulations for sustained drug delivery
EP0745401A3 (en) Medication inhaler
PL328399A1 (en) Drug administration aid
GB9701904D0 (en) A system for the delivery of drugs and therapeutic agents
PL313113A1 (en) Novel pharmaceutical agent for oral administration containing progesterone and polyethylene glycol
GB9418064D0 (en) Medicament administration inhaler
GB2305606B (en) Drug delivery composition for the nasal administration of ICAM-1
IL125820A0 (en) Therapeutic agent for diabetes and a pharmaceutical composition containing the same
EP1013269A4 (en) IMPROVEMENT OF A DRUG ADMINISTRATION SYSTEM
GB9601186D0 (en) Administration of Drugs
EP0953359A4 (en) PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION
ZA951789B (en) Pharmaceutical materials and methods of administration
HUP9903375A3 (en) Synergistic pharmaceutical compositions containing olanzapine and analgetic drugs
PL325509A1 (en) Therapeutic agent for oral administration
AU3482899A (en) Composition containing a herbal medicinal substance and a pharmaceutical drug
HUP0101012A3 (en) Pharmaceutical composition for oral administration

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees